Expression of proteins involved in cellular reprogramming [16] (including octamer-binding transcription factor 4 (Oct4), sex determining region Y-box 2 (Sox2) and Nanog) has been observed in many different types of cancer, including glioma, pancreatic, lung, prostate and breast cancer [17,18,19,20]. This evidence concerns the gene SOX2 and breast carcinoma.